APA (7th ed.) Citation

Lakhani, N. J., Rasco, D., Wang, H., Men, L., Liang, E., Fu, T., . . . Zhai, Y. (2024). First-in-Human Study with Preclinical Data of BCL-2/BCL-xL Inhibitor Pelcitoclax in Locally Advanced or Metastatic Solid Tumors. Clinical cancer research, 30(3), 506-521. https://doi.org/10.1158/1078-0432.CCR-23-1525

Chicago Style (17th ed.) Citation

Lakhani, Nehal J., et al. "First-in-Human Study with Preclinical Data of BCL-2/BCL-xL Inhibitor Pelcitoclax in Locally Advanced or Metastatic Solid Tumors." Clinical Cancer Research 30, no. 3 (2024): 506-521. https://doi.org/10.1158/1078-0432.CCR-23-1525.

MLA (9th ed.) Citation

Lakhani, Nehal J., et al. "First-in-Human Study with Preclinical Data of BCL-2/BCL-xL Inhibitor Pelcitoclax in Locally Advanced or Metastatic Solid Tumors." Clinical Cancer Research, vol. 30, no. 3, 2024, pp. 506-521, https://doi.org/10.1158/1078-0432.CCR-23-1525.